Table 1

Sociodemographic and clinical characteristics of people living with HIV who were enrolled for chronic HIV care at selected government health facilities in Afar Regional State, north-east Ethiopia from 2010 to 2011

Characteristics	Frequency	%
Age in years (mean=32.6, SD=7.5)
15–25	55	12.2
26–34	242	53.7
35–44	119	26.3
≥45	35	7.8
Sex
Male	184	40.8
Female	267	59.2
Marital status
Single	144	31.9
Married	200	44.3
Divorced	77	17.1
Widowed	30	6.7
Residence
Urban	410	90.9
Rural	41	9.1
Religion
Muslim	275	61.0
Orthodox	165	36.6
Others	11	2.4
Educational status
Illiterate	212	47.0
Primary school	177	39.2
Above secondary	62	13.8
Family size
1–3	216	47.9
4–5	159	35.3
≥5	76	16.8
Occupation
Self-employed	234	51.9
Government-employed	45	10.0
Non-employed	172	38.1
Substance use
Yes	130	28.8
No	321	71.2
Type of substance used
Tobacco	14	5.0
Alcohol	26	20.0
Both tobacco and alcohol	90	75.0
On ART
Yes	215	47.7
No	236	52.3
WHO clinical stage
I and II	200	45.4
III	172	39.0
IV	69	15.6
Bedridden
No	440	97.6
Yes	11	2.4
CD4 cell count (cells/μL)
<100	44	9.8
100–200	124	27.5
201–349	125	27.7
>350	158	35.0
BMI (kg/m²)
<18.5	218	51.7
>18.5	203	48.3
Hgb level (g/dL)
<11	344	76.3
≥11	107	23.7
CPT use
Yes	413	91.6
No	38	8.4
IPT use
Yes	94	20.8
No	357	79.2
Initial regimen
D4T-3TC-NVP	65	14.4
AZT-3TC-EFV	89	19.7
AZT-3TC-NVP	110	24.4
TDF-3TC-EFV	170	37.7
Others	17	3.8
Previous TB disease
Yes	74	16.4
No	377	83.6
Opportunistic infection
Yes	34	7.5
No	417	92.5
Chronic illness
Yes	35	7.8
No	416	92.2
Regimen change
To first line	92	20.4
To second line	4	0.9
Not changed	355	78.7
Reason for change
Due to TB development	29	30.2
Due to side effect	50	52.1
Failure of treatment	4	4.2
Others	13	13.5
Form of TB
Pulmonary	91	76.4
Extrapulmonary	28	23.6

3TC, lamivudine; ART, isoniazid preventive therapy; AZT, zidovudine; BMI, body mass index; CD4, cluster of differentiation 4; CPT, co-trimoxazole preventive therapy; D4T, stavudine; EFV, efavirenz; Hgb, haemoglobin; IPT, isoniazid preventive therapy; NVP, nevirapine; TB, tuberculosis; TDF, tenofovir.